NMDA receptors in the medial prefrontal cortex and the dorsal hippocampus regulate methamphetamine-induced hyperactivity and extracellular amino acid release in mice

Behavioural Brain Research

Volumn 232, Issue 1, 2012, Pages 44-52

  Han, Wenyan ^a   Wang, Fangyang ^a   Qi, Jia ^a,c   Wang, Fang ^a   Zhang, Lijia ^a   Zhao, Siqi ^a   Song, Ming ^b   Wu, Chunfu ^a   Yang, Jingyu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Liaoning Institute of Crime Detectives   (China)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Dorsal hippocampus; Glutamate; Kainic acid; Medial prefrontal cortex; Methamphetamine; N methyl d aspartate; Vesicular glutamate transporter 2

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; KAINIC ACID; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VESICULAR GLUTAMATE TRANSPORTER 2;

4 AMINOBUTYRIC ACID BRAIN LEVEL; AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL HIPPOCAMPUS; GABAERGIC SYSTEM; GLUTAMATERGIC SYSTEM; HIPPOCAMPUS; HYPERACTIVITY; MALE; MEDIAL PREFRONTAL CORTEX; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACIDS; ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM STIMULANTS; EXCITATORY AMINO ACID AGONISTS; EXTRACELLULAR SPACE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; HYPERKINESIS; KAINIC ACID; MALE; METHAMPHETAMINE; MICE; MICRODIALYSIS; N-METHYLASPARTATE; NEURAL PATHWAYS; PREFRONTAL CORTEX; RECEPTORS, N-METHYL-D-ASPARTATE; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 84859764373     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.03.038     Document Type: Article

References (85)

1. Tirelli E., Laviola G., Adriani W. Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents. Neurosci Biobehav Rev 2003, 27:163-178.
2. Henry B.L., Minassian A., van Rhenen M., Young J.W., Geyer M.A., Perry W. Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm. Psychopharmacology (Berl) 2011, 215(4):697-707.
3. Camarini R., Griffin W.C., Yanke A.B., Rosalina dos Santos B., Olive M.F. Effects of adolescent exposure to cocaine on locomotor activity and extracellular dopamine and glutamate levels in nucleus accumbens of DBA/2J mice. Brain Res 2008, 1193:34-42.
4. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 1998, 85(14):5274-5278.
5. Soderman A.R., Unterwald E.M. Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation. Neuroscience 2008, 154:1506-1516.
6. Ding D.C., Gabbott P.L., Totterdell S. Differences in the laminar origin of projections from the medial prefrontal cortex to the nucleus accumbens shell and core regions in the rat. Brain Res 2001, 917:81-89.
7. Narita M., Aoki K., Takagi M., Yajima Y., Suzuki T. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 2003, 119:767-775.
8. Chu P.W., Seferian K.S., Birdsall E., Truong J.G., Riordan J.A., Metcalf C.S., et al. Differential regional effects of methamphetamine on dopamine transport. Eur J Pharmacol 2008, 590:105-110.
9. Beyer C.E., Steketee J.D. Intra-medial prefrontal cortex injection of quinpirole, but not SKF 38393, blocks the acute motor-stimulant response to cocaine in the rat. Psychopharmacology (Berl) 2000, 151:211-218.
10. Hao Y., Yang J.Y., Guo M., Wu C.F., Wu M.F. Morphine decreases extracellular levels of glutamate in the anterior cingulate cortex: an in vivo microdialysis study in freely moving rats. Brain Res 2005, 1040:191-196.
11. Gonzalez A.M., Walther D., Pazos A., Uhl G.R. Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile. Brain Res Mol Brain Res 1994, 22:219-226.
12. Del Arco A., Mora F. Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex. Pharmacol Biochem Behav 2008, 90:226-235.
13. Qi J., Yang J.Y., Song M., Li Y., Wang F., Wu C.F. Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. Naunyn Schmiedebergs Arch Pharmacol 2008, 376:441-448.
14. Torregrossa M.M., Tang X.C., Kalivas P.W. The glutamatergic projection from the prefrontal cortex to the nucleus accumbens core is required for cocaine-induced decreases in ventral pallidal GABA. Neurosci Lett 2008, 438:142-145.
15. Jayaram P., Steketee J.D. Cocaine-induced increases in medial prefrontal cortical GABA transmission involves glutamatergic receptors. Eur J Pharmacol 2006, 531:74-79.
16. Meyers R.A., Zavala A.R., Speer C.M., Neisewander J.L. Dorsal hippocampus inhibition disrupts acquisition and expression, but not consolidation, of cocaine conditioned place preference. Behav Neurosci 2006, 120:401-412.
17. Lacroix L., Spinelli S., White W., Feldon J. The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion. Neuroscience 2000, 97:459-468.
18. Hao Y., Wu C.F., Yang J.Y. Lesions of the medial prefrontal cortex prevent the induction but not expression of morphine-induced behavioral sensitization in mice. Neurosci Lett 2007, 417:225-230.
19. Wolf O.T., Dyakin V., Patel A., Vadasz C., de Leon M.J., McEwen B.S., et al. Volumetric structural magnetic resonance imaging (MRI) of the rat hippocampus following kainic acid (KA) treatment. Brain Res 2002, 934:87-96.
20. Qi J., Yang J.Y., Wang F., Zhao Y.N., Song M., Wu C.F. Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 2009, 56:856-865.
21. Sorg B.A., Li N., Wu W., Bailie T.M. Activation of dopamine D1 receptors in the medial prefrontal cortex produces bidirectional effects on cocaine-induced locomotor activity in rats: effects of repeated stress. Neuroscience 2004, 127:187-196.
22. Hao Y., Yang J., Sun J., Qi J., Dong Y., Wu C.F. Lesions of the medial prefrontal cortex prevent the acquisition but not reinstatement of morphine-induced conditioned place preference in mice. Neurosci Lett 2008, 433:48-53.
23. Camarini R., Frussa-Filho R., Monteiro M.G., Calil H.M. MK-801 blocks the development of behavioral sensitization to ethanol. Alcohol Clin Exp Res 2000, 24:285-290.
24. Sirvanci S., Meshul C.K., Onat F., San T. Immunocytochemical analysis of glutamate and GABA in hippocampus of genetic absence epilepsy rats (GAERS). Brain Res 2003, 988:180-188.
25. Rezayat M., Roohbakhsh A., Zarrindast M.R., Massoudi R., Djahanguiri B. Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. Physiol Behav 2005, 84:775-782.
26. Giovannini M.G., Rakovska A., Della Corte L., Bianchi L., Pepeu G. Activation of non-NMDA receptors stimulates acetylcholine and GABA release from dorsal hippocampus: a microdialysis study in the rat. Neurosci Lett 1998, 243:152-156.
27. Black Y.D., Green-Jordan K., Eichenbaum H.B., Kantak K.M. Hippocampal memory system function and the regulation of cocaine self-administration behavior in rats. Behav Brain Res 2004, 151:225-238.
28. McGregor A., Baker G., Roberts D.C. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 1996, 53:5-9.
29. Meyers R.A., Zavala A.R., Neisewander J.L. Dorsal, but not ventral, hippocampal lesions disrupt cocaine place conditioning. Neuroreport 2003, 14:2127-2131.
30. Dai F., Yang J.Y., Gu P.F., Hou Y., Wu C.F. Effect of drug-induced ascorbic acid release in the striatum and the nucleus accumbens in hippocampus-lesioned rats. Brain Res 2006, 1125:163-170.
31. Bast T., Zhang W.N., Feldon J. Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation. Hippocampus 2003, 13:657-675.
32. Zhang W.N., Bast T., Feldon J. Effects of hippocampal N-methyl-d-aspartate infusion on locomotor activity and prepulse inhibition: differences between the dorsal and ventral hippocampus. Behav Neurosci 2002, 116(1):72-84.
33. Adams W., Ayton S., van den Buuse M. Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia. Psychopharmacology (Berl) 2009, 206(4):665-676.
34. Itoh K., Fukumori R., Suzuki Y. Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat. Life Sci 1984, 34:827-833.
35. Yoon T., Okada J., Jung M.W., Kim J.J. Prefrontal cortex and hippocampus subserve different components of working memory in rats. Learn Mem 2008, 15:97-105.
36. Lee I., Kesner R.P. Time-dependent relationship between the dorsal hippocampus and the prefrontal cortex in spatial memory. J Neurosci 2003, 23:1517-1523.
37. Hall D.A., Powers J.P., Gulley J.M. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat. Brain Res 2009, 1300:51-57.
38. Ginawi O.T., Al-Majed A.A., Al-Suwailem A.K. NAN-190, a possible specific antagonist for methamphetamine. Regul Toxicol Pharmacol 2005, 41:122-127.
39. Chazot P.L., Stephenson F.A. Biochemical evidence for the existence of a pool of unassembled C2 exon-containing NR1 subunits of the mammalian forebrain NMDA receptor. J Neurochem 1997, 68:507-516.
40. Shetty A.K., Turner D.A. Glutamic acid decarboxylase-67-positive hippocampal interneurons undergo a permanent reduction in number following kainic acid-induced degeneration of ca3 pyramidal neurons. Exp Neurol 2001, 169:276-297.
41. Hayashi Y., Kitaoka Y., Munemasa Y., Ohtani-Kaneko R., Kikusui T., Uematsu A., et al. Neuroprotective effect of 17beta-estradiol against N-methyl-D-aspartate-induced retinal neurotoxicity via p-ERK induction. J Neurosci Res 2007, 85:386-394.
42. Young S.L., Bohenek D.L., Fanselow M.S. NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: immunization against amnesia by context preexposure. Behav Neurosci 1994, 108:19-29.
43. Wang S., Lees G.J., Rosengren L.E., Karlsson J.E., Stigbrand T., Hamberger A., et al. The effect of an N-methyl-D-aspartate lesion in the hippocampus on glial and neuronal marker proteins. Brain Res 1991, 541:334-341.
44. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego. 2nd ed.
45. Zaman V., Shetty A.K. Combined neurotrophic supplementation and caspase inhibition enhances survival of fetal hippocampal CA3 cell grafts in lesioned CA3 region of the aging hippocampus. Neuroscience 2002, 109:537-553.
46. Yan P.G., Wu C.F., Huang M., Liu W. Role of nitric oxide in ethanol-induced ascorbic acid release in striatum of freely moving mice. Toxicol Lett 2003, 145:69-78.
47. Kazarian A.L., Hekimian A.A., Harutiunian-Kozak B.A., Grigorian G.G., Kozak J.A., Markarian T.M. Responses of cat's dorsal hippocampal neurones to moving visual stimuli. Acta Neurobiol Exp (Wars) 1995, 55:99-107.
48. Ashwood T.J., Wheal H.V. Loss of inhibition in the CA1 region of the kainic acid lesioned hippocampus is not associated with changes in postsynaptic responses to GABA. Brain Res 1986, 367:390-394.
49. Shreve P.E., Uretsky N.J. AMPA, kainic acid, and N-methyl-d-aspartic acid stimulate locomotor activity after injection into the substantia innominata/lateral preoptic area. Pharmacol Biochem Behav 1989, 34:101-106.
50. Watkins J.C., Jane D.E. The glutamate story. Br J Pharmacol 2006, 147(Suppl. 1):S100-S108.
51. Jackson M.E., Homayoun H., Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci U S A 2004, 101:8467-8472.
52. Montaron M.F., Deniau J.M., Menetrey A., Glowinski J., Thierry A.M. Prefrontal cortex inputs of the nucleus accumbens-nigro-thalamic circuit. Neuroscience 1996, 71:371-382.
53. Taber M.T., Das S., Fibiger H.C. Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J Neurochem 1995, 65:1407-1410.
54. Robbins T.W., Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 1996, 6:228-236.
55. Sesack S.R., Carr D.B. Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol Behav 2002, 77:513-517.
56. Jackson M.E., Moghaddam B. Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. J Neurosci 2001, 21:676-681.
57. Seamans J.K., Yang C.R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004, 74:1-58.
58. Andreas J.B., Watson M.W. Moderating effects of family environment on the association between children's aggressive beliefs and their aggression trajectories from childhood to adolescence. Dev Psychopathol 2009, 21:189-205.
59. Javitt D.C., Hashim A., Sershen H. Modulation of striatal dopamine release by glycine transport inhibitors. Neuropsychopharmacology 2005, 30:649-656.
60. Bardgett M.E., Henry J.D. Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors. Neuroscience 1999, 94:59-70.
61. Bardgett M.E., Jackson J.L., Taylor G.T., Csernansky J.G. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia. Behav Brain Res 1995, 70:153-164.
62. Wilkinson L.S., Mittleman G., Torres E., Humby T., Hall F.S., Robbins T.W. Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus. Behav Brain Res 1993, 55:143-150.
63. Peleg-Raibstein D., Feldon J. Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release. Neuropharmacology 2006, 51:947-957.
64. Swerdlow N.R., Koob G.F. Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Res 1987, 412:233-243.
65. Blaha C.D., Yang C.R., Floresco S.B., Barr A.M., Phillips A.G. Stimulation of the ventral subiculum of the hippocampus evokes glutamate receptor-mediated changes in dopamine efflux in the rat nucleus accumbens. Eur J Neurosci 1997, 9:902-911.
66. Franklin T.R., Druhan J.P. Involvement of the nucleus accumbens and medial prefrontal cortex in the expression of conditioned hyperactivity to a cocaine-associated environment in rats. Neuropsychopharmacology 2000, 23:633-644.
67. Jay T.M., Burette F., Laroche S. Plasticity of the hippocampal-prefrontal cortex synapses. J Physiol Paris 1996, 90:361-366.
68. Laroche S., Davis S., Jay T.M. Plasticity at hippocampal to prefrontal cortex synapses: dual roles in working memory and consolidation. Hippocampus 2000, 10:438-446.
69. Robertson B., Auclair F., Menard A., Grillner S., Dubuc R. GABA distribution in lamprey is phylogenetically conserved. J Comp Neurol 2007, 503:47-63.
70. Bertram E.H., Zhang D.X. Thalamic excitation of hippocampal CA1 neurons: a comparison with the effects of CA3 stimulation. Neuroscience 1999, 92:15-26.
71. Vertes R.P. Analysis of projections from the medial prefrontal cortex to the thalamus in the rat, with emphasis on nucleus reuniens. J Comp Neurol 2002, 442:163-187.
72. Thierry A.M., Gioanni Y., Degenetais E., Glowinski J. Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus 2000, 10:411-419.
73. Larson J., Quach C.N., LeDuc B.Q., Nguyen A., Rogers G.A., Lynch G. Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats. Brain Res 1996, 738:353-356.
74. Simoes P.F., Silva A.P., Pereira F.C., Marques E., Grade S., Milhazes N., et al. Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience 2007, 150:433-441.
75. Pandis C., Sotiriou E., Kouvaras E., Asprodini E., Papatheodoropoulos C., Angelatou F. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus. Neuroscience 2006, 140:163-175.
76. Lehmann A., Hansso E. Kainate-induced stimulation of amino acid release from primary astroglial cultures of the rat hippocampus. Neurochem Int 1988, 13:557-561.
77. Vertes R.P. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 2006, 142:1-20.
78. Vertes R.P., Hoover W.B., Szigeti-Buck K., Leranth C. Nucleus reuniens of the midline thalamus: link between the medial prefrontal cortex and the hippocampus. Brain Res Bull 2007, 71:601-609.
79. Kyd R.J., Bilkey D.K. Hippocampal place cells show increased sensitivity to changes in the local environment following prefrontal cortex lesions. Cereb Cortex 2005, 15:720-731.
80. Taepavarapruk P., Floresco S.B., Phillips A.G. Hyperlocomotion and increased dopamine efflux in the rat nucleus accumbens evoked by electrical stimulation of the ventral subiculum: role of ionotropic glutamate and dopamine D1 receptors. Psychopharmacology (Berl) 2000, 151:242-251.
81. Wallen-Mackenzie A., Nordenankar K., Fejgin K., Lagerstrom M.C., Emilsson L., Fredriksson R., et al. Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function. J Neurosci 2009, 29:2238-2251.
82. Moechars D., Weston M.C., Leo S., Callaerts-Vegh Z., Goris I., Daneels G., et al. Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci 2006, 26(46):12055-12066.
83. Kashani A., Lepicard E., Poirel O., Videau C., David J.P., Fallet-Bianco C., et al. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease. Neurobiol Aging 2008, 29(11):1619-1630.
84. Wallen-Mackenzie A., Gezelius H., Thoby-Brisson M., Nygard A., Enjin A., Fujiyama F., et al. Vesicular glutamate transporter 2 is required for central respiratory rhythm generation but not for locomotor central pattern generation. J Neurosci 2006, 26:12294-12307.
85. Birgner C., Nordenankar K., Lundblad M., Mendez J.A., Smith C., le Greves M., et al. VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation. Proc Natl Acad Sci U S A 2010, 107:389-394.